Le Lézard
Classified in: Health
Subject: AWD

Elizabeth ("EJ") Darling, RN, BSN, MBA, is recognized by Continental Who's Who


YUCAIPA, Calif., Oct. 17, 2017 /PRNewswire/ -- Elizabeth ("EJ") Darling, RN, BSN, MBA, is recognized by Continental Who's Who as a 2017 Pinnacle Professional and one of the Most Trusted Names in Nursing.

Elizabeth is the CEO and Founder of Nurses Knowledge, LLC. Nurses Knowledge, LLC is home to experienced nurses and healthcare professionals to foster evidence-based knowledge solutions developed by nurses, for nurses.

Possessing five decades of nursing experience, Elizabeth is a seasoned nurse having created Nurses Knowledge in 2013. In this capacity, she provides consulting in the areas of home health consulting, healthcare risk management, healthcare quality regulations and more.

Elizabeth's main focus is to bring to the forefront that nurses are capable of doing a lot at one time and that it doesn't matter how old you are when you begin your career. Elizabeth states "no one is EVER too old to continue their education and attain their career goals."

To keep up with the latest in the industry, Elizabeth maintains affiliation with the American Nurses Association, and the California Nurses Association. Additionally, she is also a certified Lay Minister with the United Methodist Church.

Initially beginning her educational career with her Associate's degree in Nursing at the College of Staten Island, Elizabeth earned her Bachelor of Science in Nursing from Thomas Edison State University. She then went on to attain her Master of Business Administration from American InterContinental University.

Contact: Katherine Green, 516-825-5634, [email protected]

 

SOURCE Continental Who's Who


These press releases may also interest you

at 06:15
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Exciting technical...

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...



News published on and distributed by: